Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Gross Margin: 2012-2020

Historic Gross Margin for Ironwood Pharmaceuticals (IRWD) over the last 9 years, with Dec 2020 value amounting to 99.19%.

  • Ironwood Pharmaceuticals' Gross Margin rose 795.00% to 99.23% in Q4 2020 from the same period last year, while for Dec 2020 it was 87.46%, marking a year-over-year decrease of 530.00%. This contributed to the annual value of 99.19% for FY2020, which is 477.00% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Gross Margin stood at 99.19% for FY2020, which was up 5.05% from 94.43% recorded in FY2019.
  • In the past 5 years, Ironwood Pharmaceuticals' Gross Margin registered a high of 99.32% during FY2016, and its lowest value of 90.55% during FY2018.
  • For the 3-year period, Ironwood Pharmaceuticals' Gross Margin averaged around 94.72%, with its median value being 94.43% (2019).
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Gross Margin slumped by 572bps in 2017 and then spiked by 477bps in 2020.
  • Ironwood Pharmaceuticals' Gross Margin (Yearly) stood at 99.32% in 2016, then plummeted by 572bps to 93.60% in 2017, then slumped by 305bps to 90.55% in 2018, then spiked by 388bps to 94.43% in 2019, then surged by 477bps to 99.19% in 2020.